Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as…
Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as part of a combination approach to treat inflammatory disorders. The startup’s launch makes it a contender in an emerging drug class that includes late-clinical assets from Merck, Roche, and partners Sanofi and Teva Pharmaceuticals. The post Inflammation Startup Bionyra Launches…
Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
Tired of watching its employers struggle to afford the cost of healthcare, Republican-controlled Indiana is trying a traditionally liberal tactic to control costs: setting government price controls on hospitals. Under a law enacted last year, five of Indiana’s largest nonprofit hospital systems cannot charge patients covered by job-based health plans more than an established price…
How Is Mayo Clinic Using AI in Its Revenue Cycle?
Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he’s skeptical that these functions will be fully automated anytime soon. The post How Is Mayo Clinic Using AI in Its Revenue Cycle? appeared first on MedCity News.
Is It Likely That the WISeR Model Will be Repealed?
Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed. The post Is It Likely That the WISeR Model Will be Repealed? appeared first on MedCity News.
Dying Without a Safety Net
America funds the crisis. It’s time to fund the care that prevents it. The post Dying Without a Safety Net appeared first on MedCity News.
Is Bias in Clinical AI Good or Bad? It’s More Complicated Than That
We do not need models that pretend every patient has equal or equitable access to care. We need models capable of recognizing disparities and responding to them. The post Is Bias in Clinical AI Good or Bad? It’s More Complicated Than That appeared first on MedCity News.
AI Can Accelerate Discovery — Development Still Decides What Advances
AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions. The post AI Can Accelerate Discovery — Development Still Decides What Advances appeared first on MedCity News.
Medicare Advantage’s Big Decision: Reset or Retreat?
Today’s adjustment offers insight into what the next phase of the program is focusing on and will subsequently reward, and why this moment matters, especially for newer and regional plans. The post Medicare Advantage’s Big Decision: Reset or Retreat? appeared first on MedCity News.
In Breach Settlements, OCR Continues to Call Out Weak Risk Analyses
Most recent settlement marks 14th enforcement action in OCR’s Risk Analysis Initiative
Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care
Through a new partnership, Marathon employer clients who don’t currently offer Lantern’s specialty care benefit can purchase it directly through Marathon. The post Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care appeared first on MedCity News.
